{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-06",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "30142-896",
      "generic_name": "acetaminophen, aspirin, caffeine",
      "labeler_name": "Kroger Company",
      "brand_name": "migraine relief",
      "active_ingredients": [
        {
          "name": "ACETAMINOPHEN",
          "strength": "250 mg/1"
        },
        {
          "name": "ASPIRIN",
          "strength": "250 mg/1"
        },
        {
          "name": "CAFFEINE",
          "strength": "65 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "30142-896-62",
          "description": "1 BOTTLE in 1 CARTON (30142-896-62)  / 24 TABLET, FILM COATED in 1 BOTTLE",
          "marketing_start_date": "20221025",
          "sample": false
        },
        {
          "package_ndc": "30142-896-78",
          "description": "1 BOTTLE in 1 CARTON (30142-896-78)  / 100 TABLET, FILM COATED in 1 BOTTLE",
          "marketing_start_date": "20191009",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "c3c1e542-884f-486e-9ab7-400106ead70b",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20191009",
      "product_id": "30142-896_c3c1e542-884f-486e-9ab7-400106ead70b",
      "application_number": "ANDA075794",
      "brand_name_base": "migraine relief",
      "pharm_class": [
        "Anti-Inflammatory Agents",
        "Non-Steroidal [CS]",
        "Central Nervous System Stimulant [EPC]",
        "Central Nervous System Stimulation [PE]",
        "Cyclooxygenase Inhibitors [MoA]",
        "Decreased Platelet Aggregation [PE]",
        "Decreased Prostaglandin Production [PE]",
        "Methylxanthine [EPC]",
        "Nonsteroidal Anti-inflammatory Drug [EPC]",
        "Platelet Aggregation Inhibitor [EPC]",
        "Xanthines [CS]"
      ]
    }
  ]
}